Strategic Partnerships Pursue pilots and licensing with transplant centers, organ procurement organizations, and large medtech/pharma players to validate and scale the donor organ repair technology, accelerating adoption within transplant workflows.

Market Opportunity The technology addresses a severe organ shortage by extending donor organ viability, creating a compelling value case for hospitals and OPOs to integrate repair capabilities into their transplantation programs.

Lean Team With grant history and revenue signals but a lean team, partner with experienced contract developers and CROs to fund trials, prepare manufacturing readiness, and navigate regulatory hurdles.

Go To Market Leverage licensing or co-development with established medical device and life sciences players to access manufacturing, distribution, and global sales channels, rather than building a large internal field force.

Regulatory Pathway Develop a regulatory and clinical plan through transplant centers and CRO collaborations to support early trials and capitalize on government grant programs and immunocloaking related applications.